Published in Cardiovascular Business Week, February 12th, 2008
"International trends indicate a shift towards the use of tissue valves in North America and Europe. In recent years, improved techniques have reduced the early mortality of these procedures, such that age, alone, is no longer an incremental risk factor. it is the co-morbidity which largely determines the fate of these patients," wrote A. Ali and colleagues.
The researchers concluded: "Percutaneous valve replacement is evolving and is likely to be a useful form of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.